Harvard Profs Sue Trump Administration Over Removal of LGBTQ Research From Website
By I. Edwards HealthDay Reporter
FRIDAY, March 14, 2025 -- Two Harvard medical school professors are suing the Trump administration, arguing that their research was unfairly removed from a government-run website.
Their studies, focused on improving patient safety and reducing medical errors, were suddenly removed allegedly because they included terms like “LGBTQ” and “transgender.”
The doctors say this move not only violates their First Amendment rights but also puts patient lives at risk, NBC News reported.
Harvard faculty members Dr. Gordon Schiff and Dr. Celeste Royce said their peer-reviewed studies were taken down from the Patient Safety Network website, which is operated by the Agency for Healthcare Research and Quality (AHRQ).
Their lawsuit — backed by the American Civil Liberties Union (ACLU) and Yale Law School’s Media Freedom and Information Access Clinic — argues that the removal is both unlawful and dangerous.
The lawsuit notes that misdiagnoses lead to death or permanent disability for about 795,000 Americans each year. The professors say their research was focused on improving medical diagnoses and patient safety.
“Allowing the government to censor research regarding patient safety for political reasons will almost assuredly increase that number,” the suit says.
One of the removed studies addressed suicide risk and mentioned LGBTQ patients, while another included the word "transgender" and covered endometriosis (a disease in which uterine tissue grows outside a woman's uterus).
Rachel Davidson, an attorney with the ACLU of Massachusetts, called the removal of these studies a serious constitutional violation.
“It is a fundamental principle of the First Amendment that the government cannot restrict speech just because it disagrees with the viewpoint of that speech,” Davidson said. “We think that is especially important in areas of scientific inquiry and debate and research.”
The lawsuit names the U.S. Office of Personnel Management, the U.S. Department of Health and Human Services, and AHRQ as defendants.
It claims the removals were made due to an executive order on gender ideology signed by President Donald Trump on January 20. It recognizes male and female as the only two sexes.
Schiff and Royce said they will not censor their medical conclusions and are pursuing legal action to protect the integrity of medical research and patient safety.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-03-15 06:00
Read more

- No Weight Loss Benefit Seen for Neoadjuvant Semaglutide Before Weight Loss Surgery
- Epstein-Barr Virus Might Help Trigger Cancer After Kidney Transplant
- De-Escalating DAPT to Ticagrelor Monotherapy Cuts Bleeding Risk in Acute Coronary Syndrome
- Women Of Color Receive Slower Response To A Bad Mammogram
- Death Risk Doubled For ER Patients On Psychedelics
- Higher Intake of Butter Linked to Increased Mortality
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions